Results 211 to 220 of about 5,854,621 (365)

Comparative study of the effects of different iron sources on bioavailability and gastrointestinal tolerability in iron-deficient rats. [PDF]

Sci Rep
Mariné-Casadó R, Tobajas Y, Antolín A, Negra T, Connolly A, Alcaide-Hidalgo JM, Caimari A.   +6 more
europepmc   +1 more source

XVIII. Notice respecting the Decomposition of Sulphate of Iron by Animal Matter.

W. H. Pepys
openalex   +1 more source

The Direction of Hair in Animals and Man . By Walter Kidd, M.D., F.Z.S. London, Adam and Charles Black. 1903. [PDF]

, 1904
Inez L. Whipple
openalex   +1 more source

Intracellular innate immune surveillance devices in plants and animals

Science, 2016
Jonathan D. G. Jones, R. Vance, J. Dangl
semanticscholar   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Vamorolone: a novel metabolism resistant steroid that suppresses joint destruction in chronic polyarthritis with reduced systemic side effects. [PDF]

Rheumatology (Oxford)
Crastin A, Shanker A, Sagmeister MS, Taylor A, Lavery GG, Raza K, Hardy RS.   +6 more
europepmc   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Intertrial interval as a contextual stimulus in discriminated operant learning. [PDF]

J Exp Psychol Anim Learn Cogn
Harlan EW, Thrailkill EA, Green JT, Bouton ME.   +3 more
europepmc   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Combined effects of <b>β</b>-hydroxybutyrate and therapeutic hypothermia in a neonatal hypoxia-ischemia model. [PDF]

J Cereb Blood Flow Metab
Fabres RB, Carvalho AVS, Silva Alós DKD, Machado DN, Spies FF, Cardoso DS, Vido MFC, Martini APR, Mattos MM, Antunes BP, Hoeper E, Venturin GT, Greggio S, Takada SH, Drobyshevsky A, de Fraga LS, Netto CA.   +16 more
europepmc   +1 more source